Aligos Therapeutics Shares Surge Ahead of Key Scientific Forums

Shares of Aligos Therapeutics Inc experienced a significant rally on Friday, climbing 6.15% to close at $11.40 after reaching an intraday peak of $11.43. This notable advance appears to reflect mounting investor anticipation for the company’s upcoming presentations at major industry conferences scheduled for the following week.

The absence of immediate news suggests the market activity is a direct response to Aligos’s previously announced participation in two pivotal events. Investor focus is centered on six preclinical presentations slated for the International HBV Meeting in Berlin (September 8-12) and an additional presentation at the H.C. Wainwright Global Investment Conference (September 8-10). Particular interest is being directed toward three presentations concerning the company’s lead candidate, ALG-000184, and a newly developed strategy for treating the hepatitis delta virus.

These Read more...